Reflections: What Really Matters  |  Teacher Insights: New Harvard Online course course prepares professionals for a data-driven world  |  Parent Interventions: Research shows lullabies in any language relax babies  |  International Edu News: 'Plastic bags could be 'eco-friendlier' than paper and cotton bags'  |  Leadership Instincts: Start-up with plastic waste recycling solution wins top prize at ideasinc 2020  |  International Edu News: Frailty, old age and comorbidity main predictors of death from Covid-19  |  Leadership Instincts: Cyber centre to reduce digital harm  |  Policy Indications: New funding to improve water security for 10 million people in Africa and Asia  |  International Edu News: UCL hosts global conference on UN Sustainable Development Goals  |  International Edu News: Medium-term impact of COVID-19 revealed in new study  |  International Edu News: Extremely rapid diagnostic test for Covid-19  |  Teacher Insights: Cambridge University Press to join with Cambridge Assessment  |  National Edu News: Minister inaugurates new Diamond Jubilee Lecture Hall Complex of NIT Jamshedpur  |  Education Information: CSIR partnered clinical trials website “CUReD” on Repurposed Drugs for Covid- 19  |  Teacher Insights: The 6th India International Science Festival to be held in Virtual format  |  
September 22, 2020 Tuesday 11:06:40 AM IST

Nearly 30 Covid vaccine candidates are under various stages of development

National Edu News

Five National COVID-19 Bio-repositories have been established by the Department of Biotechnology (DBT). This is a part of the Network of 16 COVID-19 biorepositories established in the country by Department of Biotechnology, Indian Council of Medical Research and Council of Scientific and Industrial Research. The list of biorepositories can be accessed at https://www.icmr.gov.in/cbiorn.html. The repositories are collecting clinical and viral samples. So far, 44452 clinical samples and 17 viral isolates have been collected whichare accessible to researchers and industry for developing diagnostics, therapeutics and vaccines.

The Pan India 1000 SARS-CoV-2 RNA Genome Sequencing has been successfully completed and announced on 1st August, 2020 by the Department of Biotechnology.This was led by National Institute of Biomedical Genomics (NIBMG-Kalyani), West Bengal, an Autonomous Institute of Department of Biotechnology, along with five other National clusters; clinical organizations and other hospitals.

These sequences have been uploaded on Global Initiative on Sharing All India Influenza Data (GISAID) for use by researchers across the globe.These sequences have been uploaded under the ‘Pan India 1000 SARS-CoV-2 RNA Genome Sequencing Consortium’. The link for GISAID website is https://www.gisaid.org. These are now available for use by researchers.

Nationally, nearly 30 Covid vaccine candidates are under development, by both industry and academia. These vaccines are in different stages of pre-clinical and clinical development of which 3 candidates are in advanced stage of Phase I/II/III trials and 4 are in advanced pre-clinical development stage. Support is also being extended for development of vaccine associated research resources, establishment of clinical trial sites and notifying enabling regulatory guidelines.


A high level expert group is looking into matters related to vaccine distribution and immunization. The distribution and immunization of the coronavirus vaccine are subject to availability. Once available, the Corona virus vaccine distribution follows the same route as for the current practice of vaccines distribution under Universal Immunization Program (UIP).

Comments